Portfolio (Quarterly)
Guide ↗
Medicxi Ventures Management (Jersey) Ltd
· CIK 0001715579| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | PHAT | PHATHOM PHARMACEUTICALS INC | Healthcare | 7,464,572.0 | $81.0M | 45.65% | — | — | $10.85 | -15.4% |
| 2 | — | NEWAMSTERDAM PHARMA COMPANY | — | 2,208,639.0 | $74.9M | 42.19% | -661K | -23.0% | $33.89 | — |
| 3 | AURA | AURA BIOSCIENCES INC | Healthcare | 3,039,892.0 | $21.6M | 12.16% | — | — | $7.10 | +4.2% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%